COVID-19 challenge for Industries


Pharmaceutical and biological engineers are also helping produce faster and cheaper diagnostic solutions, repurposing and developing new drugs to treat patients, isolating antibodies against the present coronavirus, and testing new vaccines. Janssen Research & Development and Moderna are accelerating the development of potential vaccines, while a team at the Wyss Institute is developing a surrogate non-COVID coronavirus for use in studies.



Meanwhile, services companies such as Ginkgo Bioworks and Twist Biosciences have offered their platform to help support technology development. And universities are putting research on hold and shifting their focus to COVID-19. In the upcoming May CEP, you can read an article that describes such work underway at Rensselaer Polytechnic Institute (RPI).


    Related Conference of COVID-19 challenge for Industries

    June 25-26, 2024

    13th World Congress on Chromatography

    Toronto, Canada
    August 22-23, 2024

    16th International Conference on Clinical Chemistry

    Berlin, Germany
    October 14-15, 2024

    4th International Conference on Analytical Chemistry

    Barcelona, Spain
    November 13-14, 2024

    5th World Expo on Biopolymers and Bioplastics

    Dubai, UAE
    December 12-13, 2024

    23rd World Congress on Nutrition and Food Chemistry

    Rome, Italy
    December 18-19, 2024

    4th International Conference on Petrochemistry and Natural Gas

    Amsterdam, Netherlands

    COVID-19 challenge for Industries Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in